Abstract
Palmer SC, Tendal B, Mustafa RA, et al. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2021;372:m4573. 33441402.
MeSH terms
-
Diabetes Mellitus, Type 2* / drug therapy
-
Glucagon-Like Peptide 1
-
Glucagon-Like Peptide-1 Receptor
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Substances
-
Glucagon-Like Peptide-1 Receptor
-
Hypoglycemic Agents
-
Sodium-Glucose Transporter 2 Inhibitors
-
Glucagon-Like Peptide 1